CA2878880C - Methods for detecting and measuring aggregation - Google Patents
Methods for detecting and measuring aggregation Download PDFInfo
- Publication number
- CA2878880C CA2878880C CA2878880A CA2878880A CA2878880C CA 2878880 C CA2878880 C CA 2878880C CA 2878880 A CA2878880 A CA 2878880A CA 2878880 A CA2878880 A CA 2878880A CA 2878880 C CA2878880 C CA 2878880C
- Authority
- CA
- Canada
- Prior art keywords
- agglutination
- sample
- assay
- particles
- erythrocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 298
- 230000002776 aggregation Effects 0.000 title description 15
- 238000004220 aggregation Methods 0.000 title description 15
- 239000000203 mixture Substances 0.000 claims abstract description 104
- 239000002245 particle Substances 0.000 claims description 500
- 230000004520 agglutination Effects 0.000 claims description 264
- 210000003743 erythrocyte Anatomy 0.000 claims description 228
- 239000000523 sample Substances 0.000 claims description 223
- 238000012800 visualization Methods 0.000 claims description 163
- 230000003612 virological effect Effects 0.000 claims description 152
- 239000012472 biological sample Substances 0.000 claims description 83
- 238000004458 analytical method Methods 0.000 claims description 57
- 230000003287 optical effect Effects 0.000 claims description 50
- 102000005348 Neuraminidase Human genes 0.000 claims description 47
- 108010006232 Neuraminidase Proteins 0.000 claims description 47
- 239000004005 microsphere Substances 0.000 claims description 34
- 238000003384 imaging method Methods 0.000 claims description 30
- 238000002203 pretreatment Methods 0.000 claims description 30
- 210000002966 serum Anatomy 0.000 claims description 24
- 230000003993 interaction Effects 0.000 claims description 22
- 238000009826 distribution Methods 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 239000011324 bead Substances 0.000 claims description 4
- 238000007818 agglutination assay Methods 0.000 abstract description 98
- 241000700605 Viruses Species 0.000 abstract description 93
- 238000010191 image analysis Methods 0.000 abstract description 48
- 238000001514 detection method Methods 0.000 abstract description 26
- 230000003053 immunization Effects 0.000 abstract description 14
- 238000002649 immunization Methods 0.000 abstract description 13
- 238000003556 assay Methods 0.000 description 235
- 230000004523 agglutinating effect Effects 0.000 description 141
- 210000004027 cell Anatomy 0.000 description 120
- 238000006243 chemical reaction Methods 0.000 description 105
- 239000008280 blood Substances 0.000 description 74
- 210000004369 blood Anatomy 0.000 description 69
- 230000035931 haemagglutination Effects 0.000 description 48
- 239000000427 antigen Substances 0.000 description 45
- 108091007433 antigens Proteins 0.000 description 45
- 102000036639 antigens Human genes 0.000 description 45
- 238000010790 dilution Methods 0.000 description 42
- 239000012895 dilution Substances 0.000 description 42
- 239000000725 suspension Substances 0.000 description 40
- 239000000463 material Substances 0.000 description 37
- 210000002381 plasma Anatomy 0.000 description 33
- 239000003153 chemical reaction reagent Substances 0.000 description 26
- 238000005259 measurement Methods 0.000 description 23
- 230000005764 inhibitory process Effects 0.000 description 21
- 238000011534 incubation Methods 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 17
- 238000005534 hematocrit Methods 0.000 description 15
- 241000282414 Homo sapiens Species 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- 238000001444 catalytic combustion detection Methods 0.000 description 14
- 238000000605 extraction Methods 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 241001529453 unidentified herpesvirus Species 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 12
- 238000005286 illumination Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 229960005486 vaccine Drugs 0.000 description 11
- 230000000007 visual effect Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000008188 pellet Substances 0.000 description 10
- 239000002953 phosphate buffered saline Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000012706 support-vector machine Methods 0.000 description 10
- 101710154606 Hemagglutinin Proteins 0.000 description 9
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 9
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 9
- 101710176177 Protein A56 Proteins 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 7
- 238000003703 image analysis method Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 239000012898 sample dilution Substances 0.000 description 7
- 238000013207 serial dilution Methods 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 108010044091 Globulins Proteins 0.000 description 6
- 102000006395 Globulins Human genes 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 238000005315 distribution function Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000010211 hemagglutination inhibition (HI) assay Methods 0.000 description 6
- 238000000386 microscopy Methods 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 241000283073 Equus caballus Species 0.000 description 5
- 241000711549 Hepacivirus C Species 0.000 description 5
- 239000010432 diamond Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 208000037798 influenza B Diseases 0.000 description 5
- 238000003909 pattern recognition Methods 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- 241000252870 H3N2 subtype Species 0.000 description 4
- 241000125945 Protoparvovirus Species 0.000 description 4
- -1 Sigma-Aldrich Substances 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 229960002086 dextran Drugs 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 208000037797 influenza A Diseases 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010008631 Cholera Diseases 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 108090001090 Lectins Proteins 0.000 description 3
- 102000004856 Lectins Human genes 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 241000709664 Picornaviridae Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 241000711931 Rhabdoviridae Species 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 108010093857 Viral Hemagglutinins Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 238000009582 blood typing Methods 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 235000011148 calcium chloride Nutrition 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000000185 hemagglutinin Substances 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000002523 lectin Substances 0.000 description 3
- 230000005499 meniscus Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 241000701242 Adenoviridae Species 0.000 description 2
- 241000712892 Arenaviridae Species 0.000 description 2
- 241001533362 Astroviridae Species 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- 241000701412 Baculoviridae Species 0.000 description 2
- 241000702628 Birnaviridae Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000520666 Carmotetraviridae Species 0.000 description 2
- 108010001857 Cell Surface Receptors Proteins 0.000 description 2
- 241000701071 Cercopithecine alphaherpesvirus 2 Species 0.000 description 2
- 241000489426 Cercopithecine betaherpesvirus 5 Species 0.000 description 2
- 241001533399 Circoviridae Species 0.000 description 2
- 241000711950 Filoviridae Species 0.000 description 2
- 241000710781 Flaviviridae Species 0.000 description 2
- 241000702463 Geminiviridae Species 0.000 description 2
- 241000700586 Herpesviridae Species 0.000 description 2
- 241000701377 Iridoviridae Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 2
- 241000218605 Macacine betaherpesvirus 3 Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000702623 Minute virus of mice Species 0.000 description 2
- 241000723741 Nodaviridae Species 0.000 description 2
- 241000712464 Orthomyxoviridae Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000711504 Paramyxoviridae Species 0.000 description 2
- 241000701945 Parvoviridae Species 0.000 description 2
- 241000701374 Polydnaviridae Species 0.000 description 2
- 241001533393 Potyviridae Species 0.000 description 2
- 241000700625 Poxviridae Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000702247 Reoviridae Species 0.000 description 2
- 241000712907 Retroviridae Species 0.000 description 2
- 241000282695 Saimiri Species 0.000 description 2
- 241000961587 Secoviridae Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000710924 Togaviridae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 108700010877 adenoviridae proteins Proteins 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 239000012911 assay medium Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000023077 detection of light stimulus Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000003067 hemagglutinative effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 241001515942 marmosets Species 0.000 description 2
- 102000006240 membrane receptors Human genes 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000012567 pattern recognition method Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 229910052703 rhodium Inorganic materials 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 125000005629 sialic acid group Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000000605 viral structure Anatomy 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001492267 Alcelaphine gammaherpesvirus 1 Species 0.000 description 1
- 208000025906 Aleutian Mink Disease Diseases 0.000 description 1
- 241000724328 Alfalfa mosaic virus Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000489422 Aotine betaherpesvirus 1 Species 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000712891 Arenavirus Species 0.000 description 1
- 241000157873 Ascoviridae Species 0.000 description 1
- 241001533466 Asfivirus Species 0.000 description 1
- 241000282706 Ateles Species 0.000 description 1
- 241000282672 Ateles sp. Species 0.000 description 1
- 241001492313 Ateline alphaherpesvirus 1 Species 0.000 description 1
- 241000701061 Ateline gammaherpesvirus 2 Species 0.000 description 1
- 241000701513 Badnavirus Species 0.000 description 1
- 241000724681 Barley yellow mosaic virus Species 0.000 description 1
- 241001429251 Beet necrotic yellow vein virus Species 0.000 description 1
- 241000405758 Betapartitivirus Species 0.000 description 1
- 241000701922 Bovine parvovirus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241001533462 Bromoviridae Species 0.000 description 1
- 241000714198 Caliciviridae Species 0.000 description 1
- 241000701931 Canine parvovirus Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000336677 Cebine betaherpesvirus 1 Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241001492329 Cercopithecine alphaherpesvirus 9 Species 0.000 description 1
- 241000705938 Cercopithecine herpesvirus 3 Species 0.000 description 1
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 description 1
- 241000684559 Chicken parvovirus Species 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 241000867610 Chlorocebus pygerythrus Species 0.000 description 1
- 241000710151 Closterovirus Species 0.000 description 1
- 241000701520 Corticoviridae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241000724252 Cucumber mosaic virus Species 0.000 description 1
- 241000022561 Cyclopis Species 0.000 description 1
- 241000702221 Cystoviridae Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000282555 Erythrocebus patas Species 0.000 description 1
- 241000121268 Erythroparvovirus Species 0.000 description 1
- 208000002613 Feline Panleukopenia Diseases 0.000 description 1
- 241000701925 Feline parvovirus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 241000701367 Fuselloviridae Species 0.000 description 1
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 241001517118 Goose parvovirus Species 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 241000057734 Gorilline gammaherpesvirus 1 Species 0.000 description 1
- 241000702620 H-1 parvovirus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000700739 Hepadnaviridae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
- 241001533448 Hypoviridae Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 241000134304 Influenza A virus H3N2 Species 0.000 description 1
- 241000702394 Inoviridae Species 0.000 description 1
- 241000714210 Leviviridae Species 0.000 description 1
- 241000701365 Lipothrixviridae Species 0.000 description 1
- 241000709757 Luteovirus Species 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 241000191851 Macacine gammaherpesvirus 4 Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000702318 Microviridae Species 0.000 description 1
- 241000701553 Myoviridae Species 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- 102000002250 NAD+ Nucleosidase Human genes 0.000 description 1
- 108010000193 NAD+ Nucleosidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241000405453 Nudiviridae Species 0.000 description 1
- 241000713112 Orthobunyavirus Species 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 241000057726 Panine gammaherpesvirus 1 Species 0.000 description 1
- 241001526370 Papiine gammaherpesvirus 1 Species 0.000 description 1
- 241001504519 Papio ursinus Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000710936 Partitiviridae Species 0.000 description 1
- 241000150350 Peribunyaviridae Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000701253 Phycodnaviridae Species 0.000 description 1
- 241000701369 Plasmaviridae Species 0.000 description 1
- 241000702072 Podoviridae Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000057733 Pongine gammaherpesvirus 2 Species 0.000 description 1
- 241000282405 Pongo abelii Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000702263 Reovirus sp. Species 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000288959 Saguinus Species 0.000 description 1
- 241000701026 Saimiriine alphaherpesvirus 1 Species 0.000 description 1
- 241000701062 Saimiriine gammaherpesvirus 2 Species 0.000 description 1
- 102100028760 Sialidase-1 Human genes 0.000 description 1
- 101710128612 Sialidase-1 Proteins 0.000 description 1
- 102100028755 Sialidase-2 Human genes 0.000 description 1
- 108050000175 Sialidase-2 Proteins 0.000 description 1
- 102100028756 Sialidase-3 Human genes 0.000 description 1
- 108050000176 Sialidase-3 Proteins 0.000 description 1
- 241000702202 Siphoviridae Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 108010011834 Streptolysins Proteins 0.000 description 1
- 241000701521 Tectiviridae Species 0.000 description 1
- 241000724318 Tenuivirus Species 0.000 description 1
- 241001533336 Tombusviridae Species 0.000 description 1
- 241000710915 Totiviridae Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 108010065667 Viral Matrix Proteins Proteins 0.000 description 1
- 108010067674 Viral Nonstructural Proteins Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000003914 blood derivative Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- G01N33/555—Red blood cell
- G01N33/556—Fixed or stabilised red blood cell
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Clinical Laboratory Science (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3153334A CA3153334A1 (en) | 2012-07-18 | 2013-07-18 | Methods for detecting and measuring aggregation |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261673215P | 2012-07-18 | 2012-07-18 | |
| US61/673,215 | 2012-07-18 | ||
| PCT/US2013/051165 WO2014015194A2 (en) | 2012-07-18 | 2013-07-18 | Methods for detecting and measuring aggregation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3153334A Division CA3153334A1 (en) | 2012-07-18 | 2013-07-18 | Methods for detecting and measuring aggregation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2878880A1 CA2878880A1 (en) | 2014-01-23 |
| CA2878880C true CA2878880C (en) | 2022-06-14 |
Family
ID=49949384
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2878880A Active CA2878880C (en) | 2012-07-18 | 2013-07-18 | Methods for detecting and measuring aggregation |
| CA3153334A Pending CA3153334A1 (en) | 2012-07-18 | 2013-07-18 | Methods for detecting and measuring aggregation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3153334A Pending CA3153334A1 (en) | 2012-07-18 | 2013-07-18 | Methods for detecting and measuring aggregation |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US9389229B2 (enExample) |
| EP (1) | EP2875354A4 (enExample) |
| JP (3) | JP2015522825A (enExample) |
| KR (1) | KR20150038155A (enExample) |
| CN (2) | CN104641234B (enExample) |
| AU (1) | AU2013292395A1 (enExample) |
| BR (1) | BR112015001087A2 (enExample) |
| CA (2) | CA2878880C (enExample) |
| IL (1) | IL236769B (enExample) |
| MX (1) | MX366275B (enExample) |
| SG (1) | SG11201500344XA (enExample) |
| WO (1) | WO2014015194A2 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3756767B1 (en) | 2007-10-02 | 2024-05-01 | Labrador Diagnostics LLC | Modular point-of-care devices and uses thereof |
| CA3097861A1 (en) | 2011-01-21 | 2012-07-26 | Labrador Diagnostics Llc | Systems and methods for sample use maximization |
| US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
| US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
| US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
| US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
| US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
| US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
| US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
| US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
| US9389229B2 (en) | 2012-07-18 | 2016-07-12 | Theranos, Inc. | Methods for detecting and measuring aggregation |
| BR112016004955B1 (pt) | 2013-09-06 | 2021-10-26 | Labrador Diagnostics Llc | Dispositivos, sistemas, métodos e conjuntos para receber cotonete |
| SG11201601611WA (en) | 2013-09-06 | 2016-04-28 | Theranos Inc | Systems and methods for detecting infectious diseases |
| TWI611173B (zh) * | 2014-07-28 | 2018-01-11 | 賽諾菲巴斯德維思設計公司 | 用於確定抗體結合活性之方法及系統 |
| US9940533B2 (en) | 2014-09-30 | 2018-04-10 | Qualcomm Incorporated | Scanning window for isolating pixel values in hardware for computer vision operations |
| US20170132466A1 (en) | 2014-09-30 | 2017-05-11 | Qualcomm Incorporated | Low-power iris scan initialization |
| US10515284B2 (en) | 2014-09-30 | 2019-12-24 | Qualcomm Incorporated | Single-processor computer vision hardware control and application execution |
| US9923004B2 (en) | 2014-09-30 | 2018-03-20 | Qualcomm Incorporated | Hardware acceleration of computer vision feature detection |
| US9986179B2 (en) | 2014-09-30 | 2018-05-29 | Qualcomm Incorporated | Sensor architecture using frame-based and event-based hybrid scheme |
| US9838635B2 (en) | 2014-09-30 | 2017-12-05 | Qualcomm Incorporated | Feature computation in a sensor element array |
| US9554100B2 (en) | 2014-09-30 | 2017-01-24 | Qualcomm Incorporated | Low-power always-on face detection, tracking, recognition and/or analysis using events-based vision sensor |
| US10728450B2 (en) | 2014-09-30 | 2020-07-28 | Qualcomm Incorporated | Event based computer vision computation |
| US9762834B2 (en) | 2014-09-30 | 2017-09-12 | Qualcomm Incorporated | Configurable hardware for computing computer vision features |
| US9704056B2 (en) | 2015-04-02 | 2017-07-11 | Qualcomm Incorporated | Computing hierarchical computations for computer vision calculations |
| WO2017100660A1 (en) * | 2015-12-09 | 2017-06-15 | Indevr, Inc. | Automated agglutination analyzer with contour comparison |
| EP3408653B1 (en) * | 2016-01-28 | 2024-01-17 | Siemens Healthcare Diagnostics Inc. | Methods and apparatus adapted to quantify a specimen from multiple lateral views |
| EP3427024A4 (en) * | 2016-02-18 | 2019-11-06 | Optofluidics, Inc. | SYSTEM AND METHOD FOR CHARACTERIZING PARTICLES IN A LIQUID SAMPLE |
| EP3249406A1 (de) * | 2016-05-27 | 2017-11-29 | PerkinElmer Cellular Technologies Germany GmbH | Verfahren zur bestimmung der anzahl von infektionsherden einer zellkultur |
| CN106092860A (zh) * | 2016-05-29 | 2016-11-09 | 江苏英诺华医疗技术有限公司 | 一种血小板活化率的检测方法 |
| EP3532985B1 (en) | 2016-10-28 | 2023-07-12 | Beckman Coulter, Inc. | Substance preparation evaluation system |
| US10614332B2 (en) | 2016-12-16 | 2020-04-07 | Qualcomm Incorportaed | Light source modulation for iris size adjustment |
| US10984235B2 (en) | 2016-12-16 | 2021-04-20 | Qualcomm Incorporated | Low power data generation for iris-related detection and authentication |
| KR101997097B1 (ko) * | 2016-12-30 | 2019-07-05 | 주식회사 이지다이아텍 | 거대 자성입자 복합체를 이용한 자동 면역분석장치 및 방법 |
| WO2018169885A1 (en) | 2017-03-12 | 2018-09-20 | Ilytica Llc | Digital molecular assays |
| CN108663527A (zh) * | 2017-03-27 | 2018-10-16 | 南京市畜牧兽医站 | 血凝和血凝抑制试验读数仪 |
| CN106980860A (zh) * | 2017-04-07 | 2017-07-25 | 广州誉康医药有限公司 | 一种用于液体介质交叉配血的结果自动判读方法 |
| US11529628B2 (en) | 2017-04-28 | 2022-12-20 | Ezdia Tech Inc. | Automated immunoassay device and method using large magnetic particle complex |
| EP3467563A1 (de) * | 2017-10-06 | 2019-04-10 | Siemens Healthcare GmbH | Mikroskopiervorrichtung |
| WO2020141463A2 (en) * | 2019-01-03 | 2020-07-09 | Pixcell Medical Technologies Ltd. | Systems and methods for analyzing a fluid sample |
| US20220137038A1 (en) * | 2019-02-06 | 2022-05-05 | Essenlix Corporation | Assays with reduced interference (iii) |
| CN114258321B (zh) * | 2019-03-12 | 2023-09-15 | 诺维卢克斯有限责任公司 | 即时浓度分析仪 |
| CN113825999A (zh) * | 2019-03-28 | 2021-12-21 | 比奥-拉德欧洲有限公司 | 用于对凝胶卡反应的图片进行分类的装置和方法 |
| CN110286239A (zh) * | 2019-08-12 | 2019-09-27 | 杭州美川合佳生物科技有限公司 | 一种血型全自动分析装置 |
| US11796446B2 (en) * | 2019-10-01 | 2023-10-24 | National Taiwan University | Systems and methods for automated hematological abnormality detection |
| JP7370573B2 (ja) * | 2019-10-03 | 2023-10-30 | 学校法人福岡大学 | 顕微鏡下凝集試験のための感染診断装置及び方法 |
| US11130994B2 (en) | 2019-12-13 | 2021-09-28 | Autonomous Medical Devices Inc. | Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method |
| US20210402392A1 (en) * | 2020-06-25 | 2021-12-30 | Autonomous Medical Devices Inc. | Apparatus and method for point of care, rapid, field-deployable diagnostic testing of covid-19, viruses, antibodies and markers, autolab 20 |
| CN115768559A (zh) | 2020-04-09 | 2023-03-07 | 伊利蒂卡有限公司 | 用于提高灵敏度的诱导聚集测定 |
| US20230152318A1 (en) | 2020-04-24 | 2023-05-18 | Siemens Healthcare Diagnostics Inc. | Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibody |
| JP7252925B2 (ja) * | 2020-06-25 | 2023-04-05 | オートノマス メディカル デバイシズ，インコーポレイテッド | ポイントオブケア（ｐｏｃ）で病原体及び抗体アレイを検出するクラウドベースの自動検出システム及び方法 |
| KR102656008B1 (ko) * | 2020-09-08 | 2024-04-11 | 경북대학교 산학협력단 | 질병 진단용 키트, 질병 진단용 키트를 이용한 질병 진단 방법 및 질병 진단용 키트의 제조 방법 |
| CN112330671B (zh) * | 2020-11-30 | 2025-07-29 | 深圳市瑞图生物技术有限公司 | 细胞分布状态的分析方法、装置、计算机设备和存储介质 |
| CA3149000A1 (en) * | 2021-03-01 | 2022-09-01 | Riam Shammaa | Kits and methods for preparing plasma injectate biostimulator |
| EP4370933A4 (en) * | 2021-07-15 | 2025-05-21 | Techcyte, Inc. | Image analysis for classifying hemagglutination and quantifying presence of antibodies |
| JP2023150022A (ja) | 2022-03-31 | 2023-10-16 | 日本光電工業株式会社 | 血液検査装置、血液検査方法、および血液検査プログラム |
| WO2025165940A1 (en) * | 2024-02-01 | 2025-08-07 | Calviri, Inc. | Methods and compositions for reducing non-tumor disease |
| US20250252576A1 (en) * | 2024-02-05 | 2025-08-07 | Diesse Diagnostica Senese S.P.A. | New apparatus for performing serum-agglutination tests |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4176174A (en) | 1974-07-19 | 1979-11-27 | Burroughs Wellcome Co. | Viral antibody diagnostic test system |
| US4197088A (en) | 1977-09-23 | 1980-04-08 | Akro-Medic Engineering, Inc. | Method for qualitative and quantitative determination of immunological reactions |
| WO1979000675A1 (fr) | 1978-02-06 | 1979-09-20 | Takeda Chemical Industries Ltd | Perfectionnements au test d'inhibition virale de l'agglutination sanguine |
| US4403037A (en) * | 1980-10-10 | 1983-09-06 | American Hoechst Corporation | Erythrocyte preparations and use thereof in hemagglutination tests |
| JPS5895248A (ja) | 1981-11-02 | 1983-06-06 | Olympus Optical Co Ltd | 粒子凝集判定用容器およびこの容器を用いる粒子凝集判定方法 |
| US4857457A (en) * | 1986-07-24 | 1989-08-15 | Shamsuddin Abulkalam M | Screening test for large intestinal cancer |
| US4829011A (en) | 1987-08-27 | 1989-05-09 | Biotrack, Inc. | Agglutination assay |
| JP2897026B2 (ja) * | 1988-10-27 | 1999-05-31 | スズキ株式会社 | 免疫学的凝集反応検出装置 |
| GB8905807D0 (en) | 1989-03-14 | 1989-04-26 | Health Lab Service Board | Particle aggregation |
| US5330897A (en) | 1989-04-27 | 1994-07-19 | South Alabama Medical Science Foundation | Sialic acid binding lectin of protozoan origin |
| US5066465A (en) | 1989-12-27 | 1991-11-19 | Olympus Optical Co., Ltd. | Reaction apparatus |
| DE4013586C2 (de) | 1990-04-27 | 1994-08-18 | Suzuki Motor Co | Vorrichtung zur Feststellung der immunologischen Agglutination |
| JPH05297001A (ja) * | 1992-04-15 | 1993-11-12 | Fujirebio Inc | 磁性粒子を用いた自動免疫測定方法及び装置 |
| JPH08304401A (ja) * | 1995-05-09 | 1996-11-22 | Fujirebio Inc | 検体の検査装置 |
| US5541417A (en) * | 1995-05-18 | 1996-07-30 | Abbott Laboratories | Quantative agglutination reaction analysis method |
| JP3706190B2 (ja) * | 1996-02-28 | 2005-10-12 | デンカ生研株式会社 | ヒトパルボウイルスｂ１９の測定方法 |
| US5994139A (en) | 1998-04-07 | 1999-11-30 | Coulter International Corp. | Stable hematology control composition and method of use |
| JPH11311625A (ja) * | 1998-04-28 | 1999-11-09 | Nikken Seibutsu Igaku Kenkyusho:Kk | 簡便な抗体価測定方法及び抗パルボウイルス抗体検出用参照抗体 |
| GB2339615B (en) | 1998-07-14 | 2001-02-07 | Cozart Bioscience Ltd | Screening device and method of screening an immunoassay test |
| GB9816088D0 (en) | 1998-07-23 | 1998-09-23 | Axis Biochemicals Asa | System |
| US7026131B2 (en) | 2000-11-17 | 2006-04-11 | Nagaoka & Co., Ltd. | Methods and apparatus for blood typing with optical bio-discs |
| US7087203B2 (en) | 2000-11-17 | 2006-08-08 | Nagaoka & Co., Ltd. | Methods and apparatus for blood typing with optical bio-disc |
| US6992819B2 (en) | 2000-12-01 | 2006-01-31 | Auburn University | High-resolution optical microscope for quick detection of pathogens |
| JP4290492B2 (ja) * | 2003-06-30 | 2009-07-08 | シスメックス株式会社 | 免疫クロマトグラフィー検査用検体前処理液、免疫クロマトグラフィー検査方法及び免疫クロマトグラフィー検査キット |
| US20070054405A1 (en) | 2003-10-23 | 2007-03-08 | Ortho-Clinical Diagnostics, Inc. | Patient sample classification based upon low angle light scattering |
| EP1708742A4 (en) * | 2003-12-05 | 2008-11-05 | Becton Dickinson Co | METHOD FOR IMPROVING THE IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND USEFUL LINKS THEREFOR |
| JP2006125994A (ja) * | 2004-10-28 | 2006-05-18 | Osaka Prefecture | インフルエンザウイルス抗原性解析用粒子 |
| WO2007053654A2 (en) | 2005-10-31 | 2007-05-10 | Cedars-Sinai Medical Center | Agglutination-based method for fast detection, isolation and quantification of apoptotic cells |
| GB0523019D0 (en) | 2005-11-11 | 2005-12-21 | Dunex Technologies Inc | Automated immunoassay apparatus |
| AT502855B1 (de) * | 2005-11-30 | 2009-10-15 | Oridis Biomed Forschungs Und E | Verfahren und vorrichtung zur automatischen zerstörungsfreien analyse einer vielzahl von biologischen proben |
| JP2009533684A (ja) * | 2006-04-14 | 2009-09-17 | カーネギー・メロン・ユニバーシティ | 核磁気共鳴技術のための細胞標識及び定量 |
| US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
| WO2008019299A2 (en) | 2006-08-04 | 2008-02-14 | Ikonisys, Inc. | Image processing method for a microscope system |
| US7718420B2 (en) | 2006-10-10 | 2010-05-18 | Postech Academy-Industry Foundation | Microfluidic biochip for blood typing based on agglutination reaction |
| EP2101917A1 (en) | 2007-01-10 | 2009-09-23 | Scandinavian Micro Biodevices A/S | A microfluidic device and a microfluidic system and a method of performing a test |
| JP5178069B2 (ja) | 2007-06-29 | 2013-04-10 | ベックマン コールター， インコーポレイテッド | Ｍｔシステムによる凝集像自動判定方法、装置、プログラムおよび記録媒体 |
| US7989177B2 (en) | 2007-08-20 | 2011-08-02 | Allied Innovative Systems, Llc | Method and device for ultrasound assisted particle agglutination assay |
| US20090214114A1 (en) | 2008-02-19 | 2009-08-27 | Diascan Ab | Pixel classification in image analysis |
| WO2009112038A2 (en) | 2008-03-14 | 2009-09-17 | Scandinavian Micro Biodevices Aps | A microfluidic system and a method of performing a test |
| WO2009119330A1 (ja) | 2008-03-24 | 2009-10-01 | 株式会社ニコン | 細胞観察の画像解析方法、画像処理プログラム及び画像処理装置 |
| WO2010002852A2 (en) | 2008-06-30 | 2010-01-07 | Vaxdesign Corp. | Bead array reader based-hemagglutination and hemagglutination inhibition assays |
| JP2010032327A (ja) * | 2008-07-28 | 2010-02-12 | Panasonic Corp | 被検出物質検出方法および被検出物質検出装置ならびに深さ位置計測方法および深さ位置計測装置 |
| US20100137159A1 (en) | 2008-10-28 | 2010-06-03 | The Board Of Regents For Oklahoma State University | Simple Tests for Rapid Detection of Canine Parvovirus Antigen and Antibodies |
| JP5426181B2 (ja) | 2009-01-21 | 2014-02-26 | シスメックス株式会社 | 検体処理システム、細胞画像分類装置、及び検体処理方法 |
| EP2491394B1 (en) | 2009-10-20 | 2018-04-18 | Sanofi Pasteur Vaxdesign Corp. | Surface-assisted hemagglutination inhibition assays |
| US20110229914A1 (en) | 2009-10-21 | 2011-09-22 | Frances Eun-Hyung Lee | Use of Antibody Secreting Cell Elispot To Assess Antibody Responses Following Antigen Exposure |
| JP5660273B2 (ja) * | 2010-01-04 | 2015-01-28 | 日本電気株式会社 | 画像診断方法、画像診断装置および画像診断プログラム |
| CA3097861A1 (en) * | 2011-01-21 | 2012-07-26 | Labrador Diagnostics Llc | Systems and methods for sample use maximization |
| US8435738B2 (en) | 2011-09-25 | 2013-05-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| EP2852841B1 (en) * | 2012-05-23 | 2017-10-11 | King Abdullah University Of Science And Technology | Microbead agglutination based assays |
| US9389229B2 (en) | 2012-07-18 | 2016-07-12 | Theranos, Inc. | Methods for detecting and measuring aggregation |
-
2013
- 2013-07-17 US US13/944,857 patent/US9389229B2/en active Active
- 2013-07-18 CN CN201380048275.6A patent/CN104641234B/zh active Active
- 2013-07-18 SG SG11201500344XA patent/SG11201500344XA/en unknown
- 2013-07-18 CA CA2878880A patent/CA2878880C/en active Active
- 2013-07-18 CN CN201910613564.5A patent/CN110346568A/zh active Pending
- 2013-07-18 JP JP2015523269A patent/JP2015522825A/ja not_active Withdrawn
- 2013-07-18 KR KR1020157004315A patent/KR20150038155A/ko not_active Ceased
- 2013-07-18 BR BR112015001087A patent/BR112015001087A2/pt not_active Application Discontinuation
- 2013-07-18 CA CA3153334A patent/CA3153334A1/en active Pending
- 2013-07-18 EP EP13820209.8A patent/EP2875354A4/en not_active Withdrawn
- 2013-07-18 WO PCT/US2013/051165 patent/WO2014015194A2/en not_active Ceased
- 2013-07-18 MX MX2015000809A patent/MX366275B/es active IP Right Grant
- 2013-07-18 AU AU2013292395A patent/AU2013292395A1/en not_active Abandoned
-
2015
- 2015-01-16 US US14/598,498 patent/US10281479B2/en active Active
- 2015-01-18 IL IL236769A patent/IL236769B/en active IP Right Grant
-
2016
- 2016-04-06 US US15/092,499 patent/US20160266142A1/en not_active Abandoned
- 2016-06-10 US US15/179,769 patent/US20170023595A1/en not_active Abandoned
-
2019
- 2019-03-29 US US16/370,167 patent/US20190293665A1/en not_active Abandoned
- 2019-06-18 JP JP2019112705A patent/JP2019148610A/ja not_active Withdrawn
-
2022
- 2022-03-04 JP JP2022033557A patent/JP2022069520A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013292395A1 (en) | 2015-01-29 |
| CA3153334A1 (en) | 2014-01-23 |
| JP2015522825A (ja) | 2015-08-06 |
| JP2022069520A (ja) | 2022-05-11 |
| SG11201500344XA (en) | 2015-02-27 |
| EP2875354A4 (en) | 2016-03-02 |
| US10281479B2 (en) | 2019-05-07 |
| IL236769A0 (en) | 2015-03-31 |
| KR20150038155A (ko) | 2015-04-08 |
| BR112015001087A2 (pt) | 2017-06-27 |
| US9389229B2 (en) | 2016-07-12 |
| CN110346568A (zh) | 2019-10-18 |
| WO2014015194A3 (en) | 2014-05-15 |
| EP2875354A2 (en) | 2015-05-27 |
| WO2014015194A2 (en) | 2014-01-23 |
| US20150198591A1 (en) | 2015-07-16 |
| HK1210266A1 (en) | 2016-04-15 |
| CN104641234B (zh) | 2019-08-06 |
| IL236769B (en) | 2019-07-31 |
| JP2019148610A (ja) | 2019-09-05 |
| US20160266142A1 (en) | 2016-09-15 |
| US20140045170A1 (en) | 2014-02-13 |
| US20170023595A1 (en) | 2017-01-26 |
| CN104641234A (zh) | 2015-05-20 |
| CA2878880A1 (en) | 2014-01-23 |
| MX2015000809A (es) | 2015-05-07 |
| US20190293665A1 (en) | 2019-09-26 |
| MX366275B (es) | 2019-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2878880C (en) | Methods for detecting and measuring aggregation | |
| US11644410B2 (en) | Systems and methods for sample use maximization | |
| Corstjens et al. | Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels | |
| Hosseini et al. | General overviews on applications of ELISA | |
| AU2018204311A1 (en) | Systems and methods for sample use maximization | |
| US20190041407A1 (en) | Devices, systems and methods for quantifying hemoglobin s concentration | |
| JP2012215419A (ja) | 測定装置及び測定プログラム | |
| HK40016218A (en) | Methods for detecting and measuring aggregation | |
| HK1210266B (zh) | 探察並測定凝集反應的方法 | |
| NZ706352B2 (en) | Systems and methods for sample use maximization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180713 |
|
| EEER | Examination request |
Effective date: 20180713 |